Back

Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction

25 August 2023 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of heart failure: effects of interventions Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Masami Nishino

Osaka Rosai Hospital, Sakai (Japan)

6 More presentations in this session

Presentation thumbnail
Association between dapagliflozin, cardiac biomarkers, and cardiac remodeling in patients with diabetes mellitus and heart failure: a post-hoc analysis of a randomized study
Doctor A. Xanthopoulos (Larissa, GR)
Abstract Slides Video
Presentation thumbnail
Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial
Doctor J. Tromp (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Intravenous iron administration in patients with heart failure alters endothelial homeostasis with early release of endothelial microvesicles and subsequent mobilization of endothelial progenitor cell
Doctor S. Mause (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction
Doctor L. Qiao (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Functional mitral regurgitation and ventricular arrhythmias in patients with cardiac resynchronization therapy
Doctor A. Yoshimura (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of heart failure: effects of interventions

The Event

Event poster

ESC Congress 2023

25 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Polypharmacy as an independent predictor of heart failure hospitalization and mortality in HFrEF patients
thumbnail
Congress Presentation
Real-world treatments and outcomes in very old patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources